Biodistribution of paclitaxel and poly(L-glutamic acid)-paclitaxel conjugate in mice with ovarian OCa-1 tumor

Cancer Chemotherapy and Pharmacology

Volumn 46, Issue 5, 2000, Pages 416-422

  Li, Chun ^a   Newman, Robert A ^a   Wu, Qing Ping ^a   Ke, Shi ^a   Chen, Wei ^a   Hutto, Toni ^a   Kan, Zuxing ^a   Brannan, Melvin D ^b   Charnsangavej, Chusilp ^a   Wallace, Sidney ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Cell Therapeutics Inc   (United States)

Author keywords

Biodistribution; Paclitaxel; Poly(L glutamic acid); Polymeric drugs

Indexed keywords

PACLITAXEL; POLYGLUTAMIC ACID;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BRAIN LEVEL; DRUG CONJUGATION; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG LIVER LEVEL; DRUG TISSUE LEVEL; DRUG TUMOR LEVEL; FEMALE; HEART; LUNG; MOUSE; MUSCLE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; SPLEEN;

EID: 0033747335     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800000168     Document Type: Article

References (24)

1. In vitro and in vivo antitumoral activity of free and encapsulated taxol
2. Bioanalysis, pharmacokinetics, and pharmacodynamics of the novel anticancer drug paclitaxel (Taxol)
3. Higher antitumor efficacy of daunomycin when linked to dextran: In vitro and in vivo studies
4. Pharmacology and toxicology of Cremophor EL diluent
5. Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. 3. Evaluation of Adriamycin conjugates against mouse leukemia L1210 in vivo
6. Plasma pharmacokinetics and tissue distribution of paclitaxel in CD2F1 mice
7. Paclitaxel pharmaceutical issues: Preparation, administration, stability, and compatibility with other medications
8. Current status of clinical trials with Taxol and docetaxel
9. Synthesis and evaluation of water-soluble polyethylene glycol paclitaxel conjugate as a paclitaxel prodrug
10. 111In-DTPA-paclitaxel in mice bearing mammary tumor
11. Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate
12. Antitumor activity of poly(L-glutamic acid)-paclitaxel on syngeneic and xenografted tumors
13. High-performance liquid chromatographic assay for Taxol in human plasma and urine and pharmacokinetics in a phase I trial
14. Conjugates of anticancer agents and polymers: Advantages of macromolecular therapeutics in vivo
15. Design, synthesis and biological activity of protaxols
16. Polymer conjugates with anticancer activity
17. Preclinical antitumor activity of water-soluble paclitaxel derivatives
18. Paclitaxel (Taxol)
19. Comparison of vascular permeability and enzymatic activation of the polymeric prodrug HPMA copolymer-doxorubicin (PK1) in human tumor xenografts
20. Novel Taxol formulations: Preparation and characterization of Taxol-containing liposomes
21. Tissue distribution, metabolism and excretion of paclitaxel in mice
22. Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxylpropyl)methacrylamide copolymer doxorubicin]: First member of a new class of chemotherapeutic agents - Drug-polymer conjugates
23. Hypersensitivity reactions from paclitaxel
24. An investigation of the antitumour activity and biodistribution of polymeric micellar paclitaxel